Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares stood at 78.17 million during the last session, with the company’s beta value hitting 0.58. At the close of trading, the stock’s price was $0.77, to imply an increase of 40.00% or $0.22 in intraday trading. The WINT share’s 52-week high remains $737.43, putting it -95670.13% down since that peak but still an impressive 53.25% since price per share fell to its 52-week low of $0.36. The company has a valuation of $2.81M, with an average of 9.74 million shares in intraday trading volume over the past 10 days and average of 2.55 million shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for Windtree Therapeutics Inc (WINT), translating to a mean rating of 3.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give WINT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.

Windtree Therapeutics Inc (NASDAQ:WINT) trade information

After registering a 40.00% upside in the last session, Windtree Therapeutics Inc (WINT) has traded red over the past five days. The 5-day price performance for the stock is 108.11%, and 2.69% over 30 days. With these gigs, the year-to-date price performance is -99.52%. Short interest in Windtree Therapeutics Inc (NASDAQ:WINT) saw shorts transact 0.93 million shares and set a 0.17 days time to cover.

WINT Dividends

Windtree Therapeutics Inc has its next earnings report out on 2025-Apr-15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders

Windtree Therapeutics Inc insiders hold 0.01% of total outstanding shares, with institutional holders owning 1.39% of the shares at 1.39% float percentage. In total, 1.39% institutions holds shares in the company.

We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St as the top two Mutual Funds with the largest holdings of the Windtree Therapeutics Inc (WINT) shares. Going by data provided on Apr 30, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 2.26 shares. This is just over 0.06% of the total shares, with a market valuation of $1740.0. Data from the same date shows that the other fund manager holds a little less at 38.0, or 0.00% of the shares, all valued at about 29.0.